This report contains market size and forecasts of Chronic Urticaria Or Hives Drug in global, including the following market information:
Global Chronic Urticaria Or Hives Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Chronic Urticaria Or Hives Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Chronic Urticaria Or Hives Drug companies in 2020 (%)
The global Chronic Urticaria Or Hives Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Urticaria Or Hives Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Urticaria Or Hives Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, By Type, 2020 (%)
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Global Chronic Urticaria Or Hives Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others
Global Chronic Urticaria Or Hives Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Urticaria Or Hives Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Chronic Urticaria Or Hives Drug revenues share in global market, 2020 (%)
Key companies Chronic Urticaria Or Hives Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Chronic Urticaria Or Hives Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Chronic Urticaria Or Hives Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Urticaria Or Hives Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Urticaria Or Hives Drug Overall Market Size
2.1 Global Chronic Urticaria Or Hives Drug Market Size: 2021 VS 2027
2.2 Global Chronic Urticaria Or Hives Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Chronic Urticaria Or Hives Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Chronic Urticaria Or Hives Drug Players in Global Market
3.2 Top Global Chronic Urticaria Or Hives Drug Companies Ranked by Revenue
3.3 Global Chronic Urticaria Or Hives Drug Revenue by Companies
3.4 Global Chronic Urticaria Or Hives Drug Sales by Companies
3.5 Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Chronic Urticaria Or Hives Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Players in Global Market
3.8.1 List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Urticaria Or Hives Drug Market Size Markets, 2021 & 2027
4.1.2 GDC-0853
4.1.3 GSK-2646264
4.1.4 BF-Derm-1
4.1.5 Bilastine
4.1.6 Others
4.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
4.2.1 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2016-2021
4.2.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2022-2027
4.2.3 By Type - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
4.3.1 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2016-2021
4.3.2 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2022-2027
4.3.3 By Type - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2016-2027
4.4 By Type - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Urticaria Or Hives Drug Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
5.2.1 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2016-2021
5.2.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2022-2027
5.2.3 By Application - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
5.3.1 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2016-2021
5.3.2 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2022-2027
5.3.3 By Application - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2016-2027
5.4 By Application - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Chronic Urticaria Or Hives Drug Market Size, 2021 & 2027
6.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
6.2.1 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2016-2021
6.2.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2022-2027
6.2.3 By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
6.3.1 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2016-2021
6.3.2 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2022-2027
6.3.3 By Region - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Chronic Urticaria Or Hives Drug Revenue, 2016-2027
6.4.2 By Country - North America Chronic Urticaria Or Hives Drug Sales, 2016-2027
6.4.3 US Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.4.4 Canada Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.4.5 Mexico Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Chronic Urticaria Or Hives Drug Revenue, 2016-2027
6.5.2 By Country - Europe Chronic Urticaria Or Hives Drug Sales, 2016-2027
6.5.3 Germany Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.5.4 France Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.5.5 U.K. Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.5.6 Italy Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.5.7 Russia Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.5.8 Nordic Countries Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.5.9 Benelux Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Chronic Urticaria Or Hives Drug Revenue, 2016-2027
6.6.2 By Region - Asia Chronic Urticaria Or Hives Drug Sales, 2016-2027
6.6.3 China Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.6.4 Japan Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.6.5 South Korea Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.6.6 Southeast Asia Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.6.7 India Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Chronic Urticaria Or Hives Drug Revenue, 2016-2027
6.7.2 By Country - South America Chronic Urticaria Or Hives Drug Sales, 2016-2027
6.7.3 Brazil Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.7.4 Argentina Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, 2016-2027
6.8.3 Turkey Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.8.4 Israel Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Chronic Urticaria Or Hives Drug Market Size, 2016-2027
6.8.6 UAE Chronic Urticaria Or Hives Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Corporate Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.1.5 AstraZeneca Plc Key News
7.2 Biofrontera AG
7.2.1 Biofrontera AG Corporate Summary
7.2.2 Biofrontera AG Business Overview
7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.2.5 Biofrontera AG Key News
7.3 ELORAC, Inc.
7.3.1 ELORAC, Inc. Corporate Summary
7.3.2 ELORAC, Inc. Business Overview
7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.3.5 ELORAC, Inc. Key News
7.4 Faes Farma, SA
7.4.1 Faes Farma, SA Corporate Summary
7.4.2 Faes Farma, SA Business Overview
7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Major Product Offerings
7.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.4.5 Faes Farma, SA Key News
7.5 Genentech, Inc.
7.5.1 Genentech, Inc. Corporate Summary
7.5.2 Genentech, Inc. Business Overview
7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.5.5 Genentech, Inc. Key News
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Corporate Summary
7.6.2 GlaxoSmithKline Plc Business Overview
7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.6.5 GlaxoSmithKline Plc Key News
7.7 J Uriach Y Compania, S.A.
7.7.1 J Uriach Y Compania, S.A. Corporate Summary
7.7.2 J Uriach Y Compania, S.A. Business Overview
7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Major Product Offerings
7.4.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.7.5 J Uriach Y Compania, S.A. Key News
7.8 Mabtech Limited
7.8.1 Mabtech Limited Corporate Summary
7.8.2 Mabtech Limited Business Overview
7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.8.5 Mabtech Limited Key News
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Corporate Summary
7.9.2 Merck & Co., Inc. Business Overview
7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.9.5 Merck & Co., Inc. Key News
7.10 Mycenax Biotech Inc.
7.10.1 Mycenax Biotech Inc. Corporate Summary
7.10.2 Mycenax Biotech Inc. Business Overview
7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.10.5 Mycenax Biotech Inc. Key News
7.11 Novartis AG
7.11.1 Novartis AG Corporate Summary
7.11.2 Novartis AG Chronic Urticaria Or Hives Drug Business Overview
7.11.3 Novartis AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.11.4 Novartis AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.11.5 Novartis AG Key News
7.12 Panacea Biotec Limited
7.12.1 Panacea Biotec Limited Corporate Summary
7.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Business Overview
7.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2016-2021)
7.12.5 Panacea Biotec Limited Key News
8 Global Chronic Urticaria Or Hives Drug Production Capacity, Analysis
8.1 Global Chronic Urticaria Or Hives Drug Production Capacity, 2016-2027
8.2 Chronic Urticaria Or Hives Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Urticaria Or Hives Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Urticaria Or Hives Drug Supply Chain Analysis
10.1 Chronic Urticaria Or Hives Drug Industry Value Chain
10.2 Chronic Urticaria Or Hives Drug Upstream Market
10.3 Chronic Urticaria Or Hives Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Urticaria Or Hives Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Chronic Urticaria Or Hives Drug in Global Market
Table 2. Top Chronic Urticaria Or Hives Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Chronic Urticaria Or Hives Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Chronic Urticaria Or Hives Drug Revenue Share by Companies, 2016-2021
Table 5. Global Chronic Urticaria Or Hives Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Chronic Urticaria Or Hives Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Chronic Urticaria Or Hives Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
Table 9. List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited